| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $10.7M | +9.2% |
| Cost of Revenue | $5.3M | -14.8% |
| Gross Profit | $5.5M | +49.6% |
| R&D Expense | $4.7M | -23.5% |
| SG&A Expense | $16.0M | -19.6% |
| Operating Income | -$15.2M | +32.0% |
| Interest Expense | $714K | -1.9% |
| Net Income | -$17.5M | +26.0% |
| EPS (Basic) | -$0.09 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $29.8M | +2396.9% |
| Accounts Receivable | $2.0M | +120.1% |
| Inventory | $545K | -52.5% |
| Current Assets | $34.2M | +775.0% |
| Total Assets | $62.9M | +479.2% |
| Current Liabilities | $4.7M | -32.4% |
| Total Liabilities | $5.5M | -57.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$17.3M | -44.9% |
| Capital Expenditures | $573K | +115.5% |
| Investing Cash Flow | -$21.6M | -1964.4% |
| Financing Cash Flow | $67.6M | +1644.9% |
| Free Cash Flow | -$17.9M | -46.5% |
| +55.0% |
| EPS (Diluted) | -$0.09 | +55.0% |
| Stockholders' Equity |
| $57.4M |
| +2731.1% |